1

Guest Opera Post: Rachel Yurman on “The Death of Klinghoffer” Controversy

 

Klinghoffer opera photoLast winter, New York’s Metropolitan Opera announced a 2014-15 season that would include its first production of a John Adams’ 1991 work, The Death of Klinghoffer.   The opera portrays the October, 1985 hijacking of a cruise ship, the Achille Lauro, by members of the Palestine Liberation Front who were seeking the release of 50 Palestinians held in Israeli prisons.   A vacationing American Jew, the wheelchair-bound Leon Klinghoffer, was shot by the hijackers.  His body was thrown overboard.

 

Controversy and protests began almost immediately after the season announcement.   The opera’s libretto, by Alice Goodman, is the source of much complaint and has been cherry-picked for lines deemed offensive and anti-Semitic.   Goodman’s text — poetic, often obscure, and perhaps ambivalent in its meaning — begins with alternating choruses that express the feelings of “Exiled Palestinians” and then “Exiled Jews.”   Besides the Klinghoffers, the other four named roles are those of the hijackers.  (Other characters have generic names, e.g., The Captain.)   By identifying the Palestinians and giving them voice, the charges go, Goodman humanizes and elevates them, while placing their politics at center stage.   Protesters even objected to the title of the opera, asking why it was called The Death of Klinghoffer and not The Murder of Klinghoffer.

These objections were accompanied by repeated calls for cancellation, as well as for a general boycott of the Met.  By spring, General Manager Peter Gelb had acquiesced to at least one demand, calling off a high-definition transmission that would have played in movie theaters around the world.    The summer’s Gaza incursion (by Israel) raised the temperature even higher:  the protesters were certain that the eight scheduled performances of Klinghoffer would provoke further incidents of anti-Semitism, in addition to those that had been reported in Europe throughout those fraught months.

In late September, opening night of the Met season featured fancy dress inside and demonstrations outside.   New York synagogue bulletins urged members to express their displeasure by writing to Mr. Gelb.  The New York Times reported that some individuals had gone further, actually finding ways to reach the performers themselves through threatening messages to their managers.  On October 20, the night of the production opening, protesters sat in a row of wheelchairs positioned opposite Lincoln Center Plaza.

Art, specifically opera, suddenly mattered.  It had become the center of a nasty, noisy, public debate.  Some music journalists reveled in the attention and in the moment of relevance for a 400-year-old form.  I, however, was incensed by the assault, and embarrassed by the willful ignorance of those who ranted while freely admitting that they had never seen the work in question.

That I love opera is often difficult to explain to those who don’t care for the sound of trained classical singing, let alone those who find it a ridiculous mode of expression.  It is improbable, but also compelling and, on the best nights, transporting.

Well-meaning friends, good people who don’t care about opera or opera-going, suddenly wanted my personal take on the argument, a ruling on the allegations of inherent anti-Semitism in Klinghoffer.   I was frustrated by their questions and by my inability to respond.   Were I to answer, I am sure that I would confound their expectations and might even offend my questioners.

I have been looking forward to seeing Klinghoffer for months now.    I’m no fan of Minimalism in music; I actively dislike the monotonous work of Philip Glass.    Although I haven’t studied the music in depth, I find that Adams offers greater texture and variety — more to intrigue the ear.  A few years ago, his Nixon in China made a deep and lasting impression on me.   Why wouldn’t I be curious to hear the next work in the line, an opera that many deem even more successful as music-drama?

Again, my friends don’t care about this.  Most aren’t really even concerned with the politics of art, only with the question of possible anti-Semitism which, in this case, is probably closer to insufficient focus on Jewish characters or inadequately expressed sympathy for their point of view.

I am not apolitical in the least, but my politics are my own, my taste in music is my own, and the terms of my Jewish identity are my own, too.   I am often inclined to choose art over strict tribal allegiance.   Richard Wagner was, by all accounts, a reprehensible man who wrote glorious music.  Many other arguably great composers were probable or certain anti-Semites.  Of this, there is nothing to be said, no dilemmas or choices to weigh.  These were the commonly-held opinions of the day.  Over time, the art has outshone and overshadowed the failings of the artists, patrons, and societies.

I doubt that The Death of Klinghoffer is “anti-Semitic,” if such a thing can be said of music itself.  It may dramatize conflicting points of view, which is usually desirable in the context of theater.    I haven’t seen the opera yet but, once I have, there might be more to say.  (Check this space in a few weeks.)   For now, I hope to be moved:  to me, that is an essential part of watching live performance.   I may feel inclined to anger, not because I expect to find the representation to be unfair, but because the acts themselves were cruel and senseless, and because music and drama can heighten emotion.    But whatever my response, I will have seen and judged Klinghoffer for its success as a work of lyric theater – my own passion – and not as an affirmation of anyone else’s politics.

 

Rachel Yurman ©2014

New Cambridge Observer is a publication of the Harris Communications Group, based in Cambridge, MA. 




BTW founder and SkeleTom sweat reaching kickstarter goal

Harold Simansky and Skeletom at Cambridge Innovation Center

Harold Simansky and Skeletom at Cambridge Innovation Center

Pleased to report that, after a stressful month, Harold Simansky’s Kickstarter campaign reached its goal of $25,000. The kickstarter will help fund BTW, a magazine devoted to beautiful, sustainable living.
Here’s a picture of Harold at the Cambridge Innovation Center—sweating it out near my favorite deskmate, SkeleTom (SkeleTom is QUIET!)  With my own Kickstarter (to help fund my forthcoming book, Ithaca Diaries,) still underway, I know that you can  feel like you’re turning into a skeleTom, waiting for contributions to roll in. Congrats to Harold and the BTW team.
–Anita M. Harris
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning marketing and PR firm based at the Cambridge Innovation Center, in Kendall Square.




Paris/Cambridge Ariana Pharma Joins Worldwide Cancer Network WIN

Butterly-from Ariana Pharma Website

Butterly-from Ariana Pharma Website

Our Cambridge Innovation Center colleague Ariana Pharma reports that it has joined the WIN consortium as an official technology partner. Congrats! Here’s the release. 

Paris, France, and Cambridge, Massachusetts USA, 29 October 2014 – Ariana Pharma, developer of innovative clinical data analysis and diagnostic solutions for the healthcare sector, today announced it has joined the WIN Consortium as an official technology partner. The Consortium (Worldwide Innovative Networking in personalized cancer medicine) is a global collaboration of 40 leading organizations whose aim is to develop more effective cancer diagnostics and therapeutics, shorten clinical trial timelines and reduce the overall cost of cancer care.

The new WIN/Ariana partnership is expected to accelerate the translation of personalized medicine discoveries into widely available new standards of care for all cancer patients, leading to significantly improved clinical outcomes and a higher quality of life for cancer patients.

As a technology partner of the WIN Consortium, Ariana will have early access to the latest research, key opinion leaders, leading academic groups and personalized medicine clinical trials. Ariana uses OncoKEM®, a proprietary clinical decision support platform for personalized medicine, to transform big data into better therapeutic decisions for cancer patients.

Ariana Pharma Founder and Chief Executive Officer Dr. Mohammad Afshar said: “We are delighted to be an official technology partner of the WIN Consortium where we can continue to leverage our expertise in patient stratification, multi-marker diagnostic optimization and data mining to transform complex clinical data into actionable information. Our expanded access to the leading global stakeholders in personalized medicine will allow us to test new hypotheses, to enhance interaction to yield valuable feedback and thus accelerate the development process and commercialisation of these critical new services for the global cancer community.”

“We are delighted to welcome Ariana Pharma in our consortium. Ariana Pharma provides outstanding computational skills enabling the translation of academic projects into commercial tools to support the therapeutic decision for cancer patients,” said Dr. John Mendelsohn, Chairman of the WIN Consortium.

WIN is recognized for pioneering the evolution of next-generation clinical trials, which test personalized treatment selection strategies rather than single drugs. These strategies are driven by algorithms that match targeted therapies or combination therapies to individual tumor biological profiles based on diagnostic analysis of genomic data and other information.

In 2013 the WIN Consortium chose Ariana Pharma to develop and globally commercialize ground-breaking decision support software in WIN’s WINTHER trial, the first state of the art clinical trial in personalized cancer medicine to help clinicians choose the best therapies for cancer patients. Ariana retains exclusive global rights to commercialize software and algorithms validated by the WINTHER clinical trial through Ariana’s OncoKEM® platform.

About Ariana Pharma

Ariana Pharma develops innovative clinical data analysis and diagnostic testing solutions to help the healthcare sector better adapt patient treatments to individual biological characteristics. Ariana Pharma’s KEM® technology enables personalization of therapies, improves the efficacy and safety of patient treatment, reduces risks and drug development costs, and accelerates time to market. KEM® is the only FDA tested technology that systematically explores combinations of biomarkers, producing more effective biomarker signatures for personalized medicine. Founded in 2003 as a spin-off of the Institut Pasteur, Paris, France, the company opened a subsidiary in the United States in 2012.For more information, please visit www.arianapharma.com

About the WIN Consortium

Founded in 2010, WIN is an initiative from the Institut Gustave Roussy (France) and University of Texas MD Anderson cancer center (USA). WIN is unique structurally in that it brings together organizations from academia, business and not-for-profits to focus on translating the latest advances in personalized cancer medicine into the standard of care. WIN is built on the recognition that all stakeholders in personalized cancer therapy must collaborate and share information, in order to effectively bring the latest innovations in personalized cancer care to the patient. WIN is a non-profit organization formed by 40 renowned members: Academic cancer centres (25 centres in 16 countries), companies (Blue Cross Blue Shield, Agilent Technologies, GE Healthcare, Oracle Health Services, Foundation Medicine, Millennium Takeda, AstraZeneca and Pfizer), non-profit organizations such as EORTC, Fondation ARC and Sage Bionetworks. WIN organizes an annual symposium in Paris dedicated to personalized medicine. For further information, please visit www.winconsortium.org  and www.winsymposium.org.

–Anita M Harris
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning pr and marketing firm based in Cambridge, MA. {Ariana is not our client]. AMH.




BTW Mag for sustainable homes kickstarter needs $3K, with 3 days to go

BTW: The Magazine of Beautiful, Healthy & Sustainable Homes's video posterWith three days to go, the kickstarter campaign for BTW (Behind the Walls)  –a multi-platform media company devoted to beautiful, healthy, energy efficient and sustainable home, .is 85% funded.  Led by our friend and Cambridge Innovation Center colleague Harold Simansky, BTW needs $3K to get to $25K tor will take in nothing at all. I hope you’ll support the project. Here’s a link to the kickstarter site:

Harold writes:

Environmentally sound, healthy homes can be as stylish as they are sustainable; as beautifully designed as they are responsible; as glam as they are green… and a lot less expensive than you might think.

Now that eco-awareness is (finally and thankfully) skyrocketing, the country has exploded with new ideas for the home—everything from innovative, energy-saving technologies and home automation systems to products, decors, and furnishings that are toxin-free, sustainable and beautiful. Now you can live a green life at home without having to choose between what’s eco-friendly and what’s style-friendly, what’s efficient and what’s expensive.

BTW is here to keep homeowners on the cutting edge, building a community that shares our vision of healthy, energy-efficient and sustainable building and renovation practices, met with beautiful design. We’re also here to educate the community about service providers and funding—in the form of thousands of rebates and incentive programs—to make that possibility a reality. We want to make it clear that living a healthy, energy-efficient, and happy green lifestyle is within reach… and it all begins in the home.

What We Do

We’re creating a vibrant community of forward-thinking homeowners with BTW: Behind the Walls, a multi-platform media company that combines a magazine (both print and online), a website, social media, videos, blog posts, creative events, and—soon to come—podcasts and ecommerce, to help consumers envision and create a new kind of home and lifestyle.

Our goal is to help all homeowners understand, as they undertake some 20 million home improvement projects every year, how to do it more efficiently, more stylishly, greener, and healthier, using the best products, services and funding.

https://www.kickstarter.com/projects/959029715/btw-the-magazine-of-beautiful-healthy-and-sustaina?ref=home_featured

–Anita M. Harris
Anita Harris is a writer and communications consultant in Cambridge, MA.
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning PR and digital marketing firm based at the Cambridge Innovation Center, in Cambridge, MA.




Millennials Support Ithaca Diaries Kickstarter Campaign

Book Cover 6x9 9-13-14 - CopyHi! I’m thrilled with the outpouring of support for Ithaca Diaries– including that of current students and recent grads.

Alex Tomasi, a 2014 Boston University communications grad (and race car driver!)  has offered a beautiful, whimsical poster as a new reward–(shown below the cover photo).

 

 

anita-poster-legalsmallYou can meet Alex and other 20-something supporters– Erin Euler, Eric Morris (Cornell 2012),  Grant Randall  and Ben Whiting  via their brief You Tube videos….and I hope at the launch party in January.

Any and all contributions welcome–including $1 and $5.  Every little bit helps–and also raises projects in the kickstarter rankings and attracts more views. It would also be great if you’d’ share this email and the kickstarter link on social media.

Here’s the kickstarter link:
https://www.kickstarter.com/projects/1639099206/ithaca-diaries-coming-of-age-in-the-1960s.

It does look like we’ll reach the goal soon…which means that Ithaca  Diaries will be available for holiday gift giving. Additional $$ will allow a Kirkus review to let bookstores and libraries know it’s available–and still more will go toward an interactive Web site.

Many many thanks,
Anita M. Harris

Anita M. Harris is a writer and communications consultant in Cambridge, MA.
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning public relations and marketing firm, based in Kendall Square, Cambridge.




CZECH “NANO ROAD SHOW” HIGHLIGHTS TINY TECH, HUGE CAPABILITIES

Nano Boston Intro + Agenda final (1)On Wednesday, October 8, a “nano road show” highlighting tiny technologies and expansive R&D capabilities of the Czech Republic came to Boston.

Sponsored by “CzechInvest,” the  Czech Republic’s investment and business development agency, and by the Consulate General of the Czech Republic, the “road show” featured six companies and research institutions with expertise in nanotechnology–a branch of engineering focused on the design and manufacture of extremely small devices built at the molecular level of matter.Radek Hasa

At an evening reception, Stanislav Benes, Head of the Economic Section of the Consulate General in New York, told me that the goals of the road show are to promote Czech companies, products and technologies; joint research, and student exchanges. “We also want to let nanotechnology centers in the US know that the Czech Republic can provide highly sophisticated, cost-effective research and development for US companies,” he said.  In addition to Boston, the road show offered presentations in Albany and New York City.

Featured companies included:

  • Nano Iron, founded in 2008, which produces tiny iron particles used to treat ground water contaminated by chlorinated hydrocarbons from industrial waste. “Our nano particles are “very reactive” and may clear an area of pollutants in months-to-years—unlike other ‘in-situ’ reagents that can take 10-to-20 years to reduce contaminants,” said Jan Slunsky, the Nano Iron CEO. “And because Nano Iron particles are composed of a naturally occurring mineral, they do not add toxicity when Nanoironinjected into a substrate.”  Other remediating processes may involve the costly transport of polluted water to distant filtration plants, he added. Nano Iron currently partners with environmental consultants and remediation companies in the Czech Republic, France, Denmark, Belgium, and the Netherlands. Nano Iron recently launched a pilot project in South Carolina.
  • Advanced Materials -JTJ, which  introduced its own industrial process of manufacturing ofphotocatalytic multifunctional paints for air purification. A number of patents protect the technology in the Czech Republic, Canada, China, South Africa, USA and many others are pending. Simultaneously, the company has developed a patented large-scale technology to produceTiO2nanoparticles withhigh efficiency.Working with several universities and international companies on variety of R&D and commercial projects, Advanced Materials – JTJ has delivered many revolutionary technologies in the field of material science, photocatalysis and energy accumulation and participates in two EC grant consortia on photocatalytic water decontamination.

    Nanord show 1

  • SYNPO, a commercially-oriented, privately held R&D center which arose in 1992 from a government-owned research center. Today, SYNPO offers new technologies and products such as coatings adhesives, composites and binders based on applied polymer science.   It focuses on contract research and development, manufacturing, process development, and nanostructured polymers and polymers from renewable raw materials. It also provides specialized analytic services, helps client companies scale up production, and trains students. Board Chairman Martin Navratil said SYNPO’s clients range from small Czech and European companies to some of the world’s largest multinational chemical companies, including DuPont, in the US.

Featured educational and research and development institutions included:

  • The Central European University of Technology (CEITEC) — a multidisciplinary science center focused on life sciences and advanced materials and technologies. CEITEC offers state-of-the-art infrastructure for research in 64 groups and 7 programs. Ceitec
  • The Technical University of LIberec Department of Nonwovens, which has a strong position in nanotechnology research thanks to its patented process of industrial-scale production of nanofibers (including nanofiber scaffolds for use in tissue engineering, and composite nanofibers).
  • The Technical University of Liberec – Institute for Nanomaterials, Advanced Technologies and Innovation (CxI), which provides long-term support of industrial research activities and utilization of new technologies and technological production methods. Its foci include competitive engineering, robotics and mechatronics, and applications of nanofiber materials.

After the meeting, Abi Barrow, director of the Boston-based Massachusetts Technology Transfer Center, said: “Nanotechnology is changing the world. It will change the way everything operates, because of the new materials people are now developing. The Czech’s have exhibited some ‘very interesting’ technology and research skills in the nanotech arena. And New England, with its own great nanotech base, has real interest in finding cost-effective ways to contract out research development and testing.”map czech

The “Nano Road Show” is one of several presentations organized by CzechInvest and the Consulate General to promote Czech prowess in a variety of fields”, said Jiri Fusek, CzechInvest’s Sector Specialist in Nanotechnology and Materials.  The Czech Republic is particularly strong in the automotive, aerospace, information and communication technologies and life science arenas, he said.

Before the event, I hadn’t realized that in the 1930´s Czechoslovakia was ranked among 10 most developed countries in the world, or that Czech scientists were instrumental in developing contact lenses and anti-HIV drugs.

Or that today,  “the Czech Republic offers the best conditions in Central and Eastern Europe  for international partnership, with US firms major investors in Czech companies,” in the words of Jan Fried, director of East Coast operations for CzechInvest. What is more,  to facilitate the entry of innovative Czech companies into the US market,  CzechInvest has sponsored   “CzechAccelerator”  for the past three years. One such program, was based in Silicon Valley; the other at the Cambridge Innovation Center, in Kendall Square.
. “As an official government organization, CzechInvest will continue to promote international investment, serve our clients, and to help Czech companies develop their businesses in the US and globally,” Fried said.

–Anita M.Harris
Anita M. Harris, an author, blogger and communications consultant,  is managing director of the Harris Communications Group, an award-winning PR and Marketing firm based in Kendall Square, Cambridge. This post was sponsored by CzechInvest.




Anita M. Harris launches kickstarter for Ithaca Diaries, Coming of Age in the 1960s

Ithaca Diaries cover

Ithaca Diaries Cover

I’m ecstatic to have finally launched a kickstarter campaign to bring Ithaca Diaries to life! And that the campaign is now already featured as a staff pick! Here’s the link…https://www.kickstarter.com/projects/1639099206/ithaca-diaries-coming-of-age-in-the-1960s?ref=category_recommended .

In case you can’t quite see the writing on the cover, left:

Ithaca Diaries is  coming of age memoir set at Cornell University in the tumultuous 1960s. The story is told in first person from the point of view of a smart, sassy, funny, scared, sophisticated yet naïve college student (moi) who can laugh at herself while she and the world around her are having a nervous breakdown. Based on diaries, letters, interviews and other primary and secondary accounts of the time, Ithaca Diariesdescribes collegiate life as protests, politics, and violence increasingly engulf the student, the campus, and the nation.  I hope my irreverent observations will serve as a prism for understanding what it was like to live through those precarious times. While often laugh-out-loud funny, I believe they provide meaningful insight into the process of political and social change from which we are reaping the benefits, today.

It would be great if you’d share this blog with anyone who might be interested….and contribute to the kickstarter campaign!
Many thanks, Anita

New Cambridge Observer is a publication of the Harris Communications Group, an award-winning PR and Marketing firm based in Cambridge, MA.
Anita Harris is it’s Managing Director. She is also the author of Broken Patterns, Professional Women and the Quest for a New Feminine Identity. 

 

 




Cambridge Art Association Fall Salon and 70th Season now open

FALL_SALON_WEBT1_Postcard-Fall-Salhe Cambridge Art Association’s 70TH exhibition year, opened Friday, September 12, with the 70th Fall Salon, CAA announced in a press release, yesterday.

The salon  runs through September 26, 2014, in both the Kathryn Schultz Gallery (25 R Lowell St)   and
University Place Galleries (125 Mt. Auburn St). Awards were presented on Friday, September 12.

CAA Event Calendar

The opening  honored the memory of longtime member and supporter Mary Schein, whose husband, Edgar Schein, has provided longtime sponsorship and support of the Fall Salon. The 70th Fall
Salon features artwork in a range of media from 144 Cambridge Art Association Artist Members.

Of the prizewinners, who were each awarded $250, Edgar Shein writes:
Jim Kociuba (Cambridge, MA) – November Rain, oil on canvas
This painting captures the style, color and content of what I always thought Mary appreciated—gentle
colors, a simple natural beautiful theme of the receding stream, and a softness of style we associated with some of the paintings of Vuillard and Redon both of whom Mary loved. I have to admit after looking them up on Google that much of their work was anything but gentle and soft, but when they did achieve it, it had a special quality that always attracted us greatly.

Susan Burgess (Cambridge, MA) – Maine Retreat, oil on canvas
This painting is a wonderful reminder of the summers Mary and I spent in Maine. We divided our time
between Bethel, where I worked, and the ocean that she loved, having grown up in Carmel, California. The two coasts are totally different, with the young California coast plunging steeply into the sea, while the geologically much older Maine coast gently eases into the ocean as this painting so elegantly shows. Our favorite places were Boothbay Harbor and Rockland where we spent several summers at the grand old Samoset Hotel. The peaceful and calming and eternal vista of this painting could be seen over and over again all along the coast.

Upcoming exhibits: 

  • Time Travelers – a small group show with work by Stephen Martin, Conny Goelz-Schmitt, and Lorraine Sullivan October 2–30, 2014. Opening reception, Thursday, October 2, 6-8pm at Kathryn Schultz Gallery
  • 70th Members Prize Show, juried by Al Miner (Assistant Curator of Contemporary Art, Museum of Fine Arts, Boston)October 10 – November 15, 2014. Opening reception: Friday, October 10, 6-8pm at University Place Gallery
  • Motion Envisioned – a small group show with work by Bea Grayson, Bob Hesse, and Ruth LieberherrNovember 4-29, 2014. Opening reception, Saturday, November 15, 1-3pm at Kathryn Schultz Gallery
  • PLATINUM – Northeast Open Show, juried by Alise Upitis (Assistant Curator, MIT List Visual Art Center)December 4, 2014 – January 16, 2015. Opening reception Friday, December 5, 6-8pm at the Kathryn Schultz Gallery and University Place Gallery.

–Anita M. Harris
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning PR and marketing firm based in Kendall Square, Cambridge, MA. 

Anita Harris is a communications consultant and the author of Broken Patterns, Professional Women and the Quest for a New Femninine Identity (2014) and the forthcoming Ithaca Diaries, Coming of Age in the 1960s. (Spring, 2015).